Solid second quarter 2013 for Gerresheimer

Duesseldorf (ots) -

- Cross reference: The press release including Group Key Figures
is available at http://www.presseportal.de/dokumente -

- Second-quarter revenues up 4.2% to EUR 327.1m
- Adjusted EBITDA of EUR 59.8m slightly above prior-year quarter
(up 0.5%)
- Adjusted net income at EUR 21.5m (up 0.9%)
- Adjusted earnings per share on a par with prior-year quarter, at
EUR 0.63
- Guidance for financial year 2013 made more specific

Gerresheimer AG, one of the leading partners to the pharma and
healthcare industry worldwide, generated solid figures in the second
quarter of the 2013 financial year. "Our strategy is geared to
sustained, profitable growth. We continue to be successful in
implementing that strategy. In the second quarter, we saw notable
growth particularly in our medical systems for drug delivery and in
pharmaceutical plastic packaging. Our latest acquisitions in India
are also developing very well," said Uwe Röhrhoff, CEO of
Gerresheimer AG.

Gerresheimer increased revenues in the second quarter of financial
year 2013 (financial year from December 1 to November 30) by 4.2% to
EUR 327.1m. The revenue growth mainly reflects strong business in the
Plastic Systems Division with pharmaceutical primary packaging,
insulin pens and inhalers. Triveni, an Indian company specializing in
pharmaceutical plastic packaging acquired in December 2012, likewise
contributed to the increase in revenues. The Moulded Glass Division
generated healthy growth rates notably with the sale of cosmetic
glass packaging.

Gerresheimer recorded adjusted EBITDA of EUR 59.8m in the second
quarter of 2013, an increase of 0.5% on the prior-year quarter. The
adjusted EBITDA margin was 18.3%, below the 19.0% margin in the
comparative period. The main causes of the decreased margin comprised
the anticipated high cost of improving the production of prefillable
syringes at a German plant and quality problems in the manufacture of
glass ampoules identified at a Mexican plant during the second
quarter.

Adjusted net income for the second quarter came to EUR 21.5m, 0.9%
more than in the prior-year quarter (EUR 21.3m). Adjusted earnings
per share were exactly on a par with the prior-year quarter, at EUR
0.63. Gerresheimer's capital expenditure in the second quarter of
2013 was EUR 33.4m, EUR 2.0m more than a year earlier.

Outlook

For financial year 2013, Gerresheimer continues to expect revenue
growth of 5% to 6% at constant exchange rates. For adjusted EBITDA,
the company has made its guidance more specific with a range of
between EUR 245m and EUR 250m. Attainment of the revenue growth
guidance of 5% to 6% would correspond to a potential adjusted EBITDA
margin range of approximately 19.0% to 19.4%. Largely due to the
healthy growth prospects in the Plastic Systems Division, capital
expenditure in financial year 2013 will represent some 9% to 10% of
exchange rate adjusted revenues.

The online annual report is available at:
http://annualreport2012.gerresheimer.com

Contact:
Jens Kürten
Director Corporate Communication & Marketing
Phone +49 211 6181-250
Fax +49 211 6181-241
E-Mail j.kuerten@gerresheimer.com
Internet www.gerresheimer.com